Health and Healthcare

Celgene : CELG

All CELG Articles

433 Articles

Chris Lange | Jan 20, 2016 at 11:45 AM EST

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. It initiated several top biotech stocks…

Jon C. Ogg | Jan 20, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

Wednesday's top analyst calls include AMD, Amazon.com, Celgene, Comerica, Fortinet, Gilead Sciences, Lennar, Netflix, Voya and Wayfair.

Chris Lange | Jan 16, 2016 at 10:25 AM EST

5 Stocks That Punished Shareholders Last Week

While these were not the five biggest absolute losers of the week, of the active stocks, these all issued news…

Lee Jackson | Jan 14, 2016 at 8:35 AM EST

3 Top Jefferies Biotech Stocks to Buy for 2016 With Huge Upside Potential

These companies are well along in clinical trials and some are close to presenting Phase 3 results. Sticking with industry…

Chris Lange | Jan 13, 2016 at 8:35 AM EST

Short Interest Remains Mixed for Major Biotechs

The short interest data are out for the December 31 settlement date. 24/7 Wall St. has reviewed the top biotech…

Chris Lange | Jan 11, 2016 at 12:40 PM EST

Celgene Disappoints Investors by Meeting Estimates

Celgene Corp. (NASDAQ: CELG) sank in Monday's session after providing a business update that was largely in line with analyst…

Jon C. Ogg | Jan 6, 2016 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More

The top analyst calls for Wednesday, January 6, 2016, include Bluebird Bio, Check Point Software, Comcast, Eli Lilly, Hyatt Hotels,…

Lee Jackson | Dec 30, 2015 at 9:55 AM EST

Baird Is Bullish on 3 Very Hot Stocks Poised for 2016 Potential Upside

Baird has maintained Outperform ratings on three top companies that have reported outstanding numbers and had positive catalysts. All three…

Chris Lange | Dec 28, 2015 at 8:40 AM EST

Short Interest Remains Mixed in Major Biotechs

The short interest data are out for the December 15 settlement date, and short interest continued to be mixed in…

Jon C. Ogg | Dec 24, 2015 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Celgene, DigitalGlobe, Micron, Paychex, Bed Bath & Beyond and Many More

The top analyst calls for Thursday include Celgene, DigitalGlobe, Micron Technology, Paychex and Bed Bath & Beyond.

Jon C. Ogg | Dec 23, 2015 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Apple, Celgene, GE, Micron, Nike, ONEOK, Darden, Delphi and Many More

Wednesday’s top analyst upgrades, downgrades and initiations includes Apple, Celgene, General Electric, Micron Technology, Nike, ONEOK, Darden Restaurants and Delphi…

Chris Lange | Dec 10, 2015 at 8:40 AM EST

Mixed Views on Major Biotech Short Interest

The November 30 short interest data have been compared with the previous report, and short interest was mixed in these…

Lee Jackson | Dec 8, 2015 at 8:25 AM EST

Blue Chip Biotech Highlights Jefferies 4 Top Growth Stocks to Buy Now

A new Jefferies research report features some solid new growth stock calls that make good sense for people looking to…

Lee Jackson | Dec 3, 2015 at 11:05 AM EST

Merrill Lynch Has 5 Blue Chips That Lagged This Year to Buy for 2016

A Merrill Lynch report focuses on five top stocks that underperformed this year but that could outperform in 2016.

Chris Lange | Nov 25, 2015 at 9:06 AM EST

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the short interest data on the top biotech companies.

1 … 13 14 15 16 17 … 29

Celgene : CELG

All CELG Articles

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

5 Stocks That Punished Shareholders Last Week

3 Top Jefferies Biotech Stocks to Buy for 2016 With Huge Upside Potential

Short Interest Remains Mixed for Major Biotechs

Celgene Disappoints Investors by Meeting Estimates

Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More

Baird Is Bullish on 3 Very Hot Stocks Poised for 2016 Potential Upside

Short Interest Remains Mixed in Major Biotechs

Top Analyst Upgrades and Downgrades: Celgene, DigitalGlobe, Micron, Paychex, Bed Bath & Beyond and Many More

Top Analyst Upgrades and Downgrades: Apple, Celgene, GE, Micron, Nike, ONEOK, Darden, Delphi and Many More

Mixed Views on Major Biotech Short Interest

Blue Chip Biotech Highlights Jefferies 4 Top Growth Stocks to Buy Now

Merrill Lynch Has 5 Blue Chips That Lagged This Year to Buy for 2016

Short Sellers Run for Cover From Major Biotechs

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Celgene : CELG

All CELG Articles

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

5 Stocks That Punished Shareholders Last Week

3 Top Jefferies Biotech Stocks to Buy for 2016 With Huge Upside Potential

Short Interest Remains Mixed for Major Biotechs

Celgene Disappoints Investors by Meeting Estimates

Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More

Baird Is Bullish on 3 Very Hot Stocks Poised for 2016 Potential Upside

Short Interest Remains Mixed in Major Biotechs

Top Analyst Upgrades and Downgrades: Celgene, DigitalGlobe, Micron, Paychex, Bed Bath & Beyond and Many More

Top Analyst Upgrades and Downgrades: Apple, Celgene, GE, Micron, Nike, ONEOK, Darden, Delphi and Many More

Mixed Views on Major Biotech Short Interest

Blue Chip Biotech Highlights Jefferies 4 Top Growth Stocks to Buy Now

Merrill Lynch Has 5 Blue Chips That Lagged This Year to Buy for 2016

Short Sellers Run for Cover From Major Biotechs

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%